Published in Hum Gene Ther on February 10, 1998
Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. N Engl J Med (1999) 9.02
Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother Pharmacol (1989) 7.47
Potential contribution of computer-aided detection to the sensitivity of screening mammography. Radiology (2000) 4.02
Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma. Nature (1985) 3.50
High rate of HTLV-II infection in seropositive i.v. drug abusers in New Orleans. Science (1989) 3.00
Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children's Oncology Group. J Clin Oncol (2005) 2.97
Analysis of rev gene function on human immunodeficiency virus type 1 replication in lymphoid cells by using a quantitative polymerase chain reaction method. J Virol (1989) 2.67
Identification of the gene responsible for human T-cell leukaemia virus transcriptional regulation. Nature (1986) 2.49
Increase of ceramide and induction of mixed apoptosis/necrosis by N-(4-hydroxyphenyl)- retinamide in neuroblastoma cell lines. J Natl Cancer Inst (1999) 2.49
The x gene is essential for HTLV replication. Science (1985) 2.44
Radiation risk from mammography: is it clinically significant? AJR Am J Roentgenol (1984) 2.15
Chemotherapy plus local treatment in the management of intraocular retinoblastoma. Arch Ophthalmol (1996) 1.95
Consolidation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma: a report of two concurrent Children's Cancer Group studies. J Clin Oncol (1996) 1.94
High levels of p19/nm23 protein in neuroblastoma are associated with advanced stage disease and with N-myc gene amplification. J Clin Invest (1991) 1.70
Stability of malignant breast microcalcifications. Radiology (1994) 1.48
Analysis of clinically occult and mammographically occult breast tumors. AJR Am J Roentgenol (1977) 1.46
Chemotherapy for induction of remission of childhood acute myeloid leukemia followed by marrow transplantation or multiagent chemotherapy: a report from the Childrens Cancer Group. J Clin Oncol (1994) 1.45
Breast imaging case of the day. Spontaneously disappearing benign calcifications of the breast. Radiographics (1999) 1.45
Failure of recombinant human interleukin-3 therapy to induce erythropoiesis in patients with refractory Diamond-Blackfan anemia. Blood (1994) 1.45
Drug resistance patterns of human neuroblastoma cell lines derived from patients at different phases of therapy. Cancer Res (1998) 1.45
Insulin-like growth factor I expression by tumors of neuroectodermal origin with the t(11;22) chromosomal translocation. A potential autocrine growth factor. J Clin Invest (1990) 1.44
Loss of p53 function confers high-level multidrug resistance in neuroblastoma cell lines. Cancer Res (2001) 1.44
A second isolate of HTLV-II associated with atypical hairy-cell leukemia. N Engl J Med (1986) 1.44
Phase I trial of 13-cis-retinoic acid in children with neuroblastoma following bone marrow transplantation. J Clin Oncol (1995) 1.42
Prognostic value of immunocytologic detection of bone marrow metastases in neuroblastoma. N Engl J Med (1991) 1.42
Unrelated umbilical cord stem cell transplantation for X-linked immunodeficiencies. J Pediatr (2001) 1.41
Mammographically detected breast cancer. Nonpalpable is not a synonym for inconsequential. Cancer (1994) 1.39
Breast imaging case of the day. Intracystic papillary carcinoma of the breast. Radiographics (1998) 1.38
Imaging of the radiographically dense breast. Radiology (1993) 1.36
Detection and cloning of new HTLV-related endogenous sequences in man. Nucleic Acids Res (1989) 1.36
Modeling human lymphoid precursor cell gene therapy in the SCID-hu mouse. Blood (1994) 1.33
Quantitative tumor cell content of bone marrow and blood as a predictor of outcome in stage IV neuroblastoma: a Children's Cancer Group Study. J Clin Oncol (2000) 1.33
N-(4-hydroxyphenyl)retinamide elevates ceramide in neuroblastoma cell lines by coordinate activation of serine palmitoyltransferase and ceramide synthase. Cancer Res (2001) 1.32
The essential role of Saccharomyces cerevisiae CDC6 nucleotide-binding site in cell growth, DNA synthesis, and Orc1 association. J Biol Chem (1999) 1.31
Synergistic cytotoxicity in solid tumor cell lines between N-(4-hydroxyphenyl)retinamide and modulators of ceramide metabolism. J Natl Cancer Inst (2000) 1.31
Phase I dose escalation of 131I-metaiodobenzylguanidine with autologous bone marrow support in refractory neuroblastoma. J Clin Oncol (1998) 1.30
Patterns of repair of dystrophic mouse muscle: studies on isolated fibers. Dev Dyn (1999) 1.29
Pneumococcal infections after human bone-marrow transplantation. Ann Intern Med (1979) 1.23
Characterization of human neuroblastoma cell lines established before and after therapy. J Natl Cancer Inst (1986) 1.22
Human T-cell leukemia viruses: epidemiology, biology, and pathogenesis. Blood Rev (1997) 1.22
Activation of the GM-CSF promoter by HTLV-I and -II tax proteins. Oncogene (1989) 1.22
Aging normal and dystrophic mouse muscle: analysis of myogenicity in cultures of living single fibers. Muscle Nerve (1998) 1.21
Bone marrow transplantation in severe combined immunodeficiency from a sibling who had received a paternal bone marrow transplant. N Engl J Med (1996) 1.17
Differential protooncogene expression characterizes histopathologically indistinguishable tumors of the peripheral nervous system. J Clin Invest (1987) 1.15
Lentivirus vectors using human and simian immunodeficiency virus elements. J Virol (1999) 1.15
Radiologists' preferences for digital mammographic display. The International Digital Mammography Development Group. Radiology (2000) 1.14
Olfactory neuroblastoma is a peripheral primitive neuroectodermal tumor related to Ewing sarcoma. Proc Natl Acad Sci U S A (1996) 1.13
Stereotactic core-needle breast biopsy: a multi-institutional prospective trial. Radiology (2001) 1.12
N-(4-hydroxyphenyl)retinamide increases ceramide and is cytotoxic to acute lymphoblastic leukemia cell lines, but not to non-malignant lymphocytes. Leukemia (2002) 1.12
Relative prevalence and risk factors of HTLV-I and HTLV-II infection in US blood donors. Lancet (1991) 1.12
Treatment of neuroblastoma patients with antiganglioside GD2 antibody plus interleukin-2 induces antibody-dependent cellular cytotoxicity against neuroblastoma detected in vitro. J Immunother Emphasis Tumor Immunol (1994) 1.12
Is there a role for retinoids to treat minimal residual disease in neuroblastoma? Br J Cancer (2000) 1.11
Multicentricity of non-palpable breast cancer. Cancer (1980) 1.10
N-myc gene amplification in neuroblastoma is associated with altered phosphorylation of a proliferation related polypeptide (Op18). Oncogene (1990) 1.10
Chemotherapy without irradiation--a novel approach for newly diagnosed CNS germ cell tumors: results of an international cooperative trial. The First International Central Nervous System Germ Cell Tumor Study. J Clin Oncol (1996) 1.08
Homozygous deletion of CDKN2A (p16INK4a/p14ARF) but not within 1p36 or at other tumor suppressor loci in neuroblastoma. Cancer Res (2001) 1.08
A histochemical method for the simultaneous demonstration of capillaries and fiber type in skeletal muscle. Stain Technol (1987) 1.07
Patterns of relapse after autologous purged bone marrow transplantation for neuroblastoma: a Childrens Cancer Group pilot study. J Clin Oncol (1993) 1.07
Developing asymmetric breast tissue. Radiology (1999) 1.06
Pathogenesis of vertebral metastasis and epidural spinal cord compression. Cancer (1990) 1.06
Establishment of human T-cell leukemia virus type I T-cell lymphomas in severe combined immunodeficient mice. Blood (1993) 1.06
The pathology of breast cancer detected by mass population screening. Cancer (1977) 1.05
Lumpectomy and level I axillary dissection prior to irradiation for "operable" breast cancer. Ann Surg (1984) 1.05
Regulation of HTLV-II gene expression by Rex involves positive and negative cis-acting elements in the 5'long terminal repeat. Virology (1991) 1.04
Polypyrimidine tract-binding protein and heterogeneous nuclear ribonucleoprotein A1 bind to human T-cell leukemia virus type 2 RNA regulatory elements. J Virol (1995) 1.03
In vitro mutagenesis of the human T-cell leukemia virus types I and II tax genes. J Virol (1989) 1.03
Human T-cell leukemia virus type II Rex binding and activity require an intact splice donor site and a specific RNA secondary structure. J Virol (1991) 1.03
Characterization of human marrow stromal cells: role in progenitor cell binding and granulopoiesis. Blood (1989) 1.03
Energy metabolism in human erythrocytes. I. Effects of sodium fluoride. J Clin Invest (1971) 1.03
Heterogeneity of intraductal carcinoma of the breast. Cancer (1989) 1.02
Specific binding of polypyrimidine tract binding protein and hnRNP A1 to HIV-1 CRS elements. Virus Genes (1996) 1.02
Superficial thrombophlebitis of the breast (Mondor's disease): mammographic findings. AJR Am J Roentgenol (1993) 1.02
Clinically occult breast cancer. Multicentricity and implications for treatment. Ann Surg (1980) 1.01
Selective toxicity of 6-hydroxydopamine and ascorbate for human neuroblastoma in vitro: a model for clearing marrow prior to autologous transplant. Cancer Res (1982) 1.01
Evaluation of new imaging procedures for breast cancer: proper process. AJR Am J Roentgenol (1983) 1.01
Treatment of acute myelogenous leukemia. A prospective controlled trial of bone marrow transplantation versus consolidation chemotherapy. Ann Intern Med (1985) 1.00
Bone-marrow transplantation for metachromatic leucodystrophy. Lancet (1985) 1.00
Reasons for failure of a mammography unit at clinical image review in the American College of Radiology Mammography Accreditation Program. Radiology (2000) 0.99
The Canadian National Breast Screening Study: a critical review. AJR Am J Roentgenol (1993) 0.99
Roles of p53 and caspases in the induction of cell cycle arrest and apoptosis by HIV-1 vpr. Exp Cell Res (1999) 0.99
Energy metabolism in human erythrocytes: the role of phosphoglycerate kinase in cation transport. Blood (1975) 0.99
Role of myeloablative therapy in improved outcome for high risk neuroblastoma: review of recent Children's Cancer Group results. Eur J Cancer (1995) 0.98
Effect of myeloablative bone marrow transplantation on growth in children with sickle cell anaemia: results of the multicenter study of haematopoietic cell transplantation for sickle cell anaemia. Br J Haematol (2007) 0.98
Clinicopathologic correlations and significance of clinically occult mammary lesions. Cancer (1978) 0.98
Allogeneic versus autologous purged bone marrow transplantation for neuroblastoma: a report from the Childrens Cancer Group. J Clin Oncol (1994) 0.98
Energy metabolism in human erythrocytes. II. Effects of glucose depletion. J Clin Invest (1972) 0.98
Mutation of the methylated tRNA(Lys)(3) residue A58 disrupts reverse transcription and inhibits replication of human immunodeficiency virus type 1. J Virol (2001) 0.97
Multiparameter flow cytometric analysis of human fetal bone marrow B cells. Leukemia (1990) 0.97
Cross-resistance of topoisomerase I and II inhibitors in neuroblastoma cell lines. Cancer Chemother Pharmacol (2000) 0.96
13-cis-retinoic acid (NSC 122758) in the treatment of children with metastatic neuroblastoma unresponsive to conventional chemotherapy: report from the Childrens Cancer Study Group. Med Pediatr Oncol (1992) 0.96
Buthionine sulphoximine alone and in combination with melphalan (L-PAM) is highly cytotoxic for human neuroblastoma cell lines. Eur J Cancer (1997) 0.96
Challenges in the use of allogeneic hematopoietic SCT for ectodermal dysplasia with immune deficiency. Bone Marrow Transplant (2008) 0.96
Postremission therapy for children with acute myeloid leukemia: the children's cancer group experience in the transplant era. Leukemia (2005) 0.95
In vivo properties of three human HER2/neu-expressing murine cell lines in immunocompetent mice. Lab Anim Sci (1999) 0.95
Inhibition of HIV-1 replication using a mutated tRNALys-3 primer. J Biol Chem (1997) 0.95
Clinically occult breast lesions: localization and significance. Radiology (1987) 0.95
Ectopic skeletal muscles derived from myoblasts implanted under the skin. J Cell Sci (1998) 0.94
Depletion of glutathione by buthionine sulfoxine is cytotoxic for human neuroblastoma cell lines via apoptosis. Exp Cell Res (1999) 0.94